Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and Golcadomide in Older Frail Patients With DLBCL
NCT06835530Phase 2Recruiting
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Apr 2025
- Primary completion
- Apr 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of golcadomide in diffuse large B-cell lymphoma (DLBCL), sponsored by Fondazione Italiana Linfomi. Started Apr 2025; status: recruiting.
02
Drugs
golcadomide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT06835530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06835530.